National Institute of Chemistry, SI-1000 Ljubljana, Slovenia.
Graduate School of Biomedicine, Faculty of Medicine, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Int J Mol Sci. 2020 Oct 16;21(20):7687. doi: 10.3390/ijms21207687.
Cardioprotection against ischemia/reperfusion injury is still an unmet clinical need. The transient activation of Toll-like receptors (TLRs) has been implicated in cardioprotection, which may be achieved by treatment with blood-derived extracellular vesicles (EVs). However, since the isolation of EVs from blood takes considerable effort, the aim of our study was to establish a cellular model from which cardioprotective EVs can be isolated in a well-reproducible manner. EV release was induced in HEK293 cells with calcium ionophore A23187. EVs were characterized and cytoprotection was assessed in H9c2 and AC16 cell lines. Cardioprotection afforded by EVs and its mechanism were investigated after 16 h simulated ischemia and 2 h reperfusion. The induction of HEK293 cells by calcium ionophore resulted in the release of heterogenous populations of EVs. In H9c2 and AC16 cells, stressEVs induced the downstream signaling of TLR4 and heme oxygenase 1 (HO-1) expression in H9c2 cells. StressEVs decreased necrosis due to simulated ischemia/reperfusion injury in H9c2 and AC16 cells, which was independent of TLR4 induction, but not that of HO-1. Calcium ionophore-induced EVs exert cytoprotection by inducing HO-1 in a TLR4-independent manner.
心肌缺血/再灌注损伤的保护仍然是未满足的临床需求。瞬时激活 Toll 样受体 (TLRs) 与心肌保护有关,这可以通过用血液来源的细胞外囊泡 (EVs) 治疗来实现。然而,由于从血液中分离 EVs 需要相当大的努力,因此我们的研究目的是建立一种细胞模型,以便以可重复的方式从该模型中分离出具有心脏保护作用的 EVs。使用钙离子载体 A23187 诱导 HEK293 细胞释放 EVs。对 H9c2 和 AC16 细胞系进行 EVs 的特征描述和细胞保护评估。在模拟缺血 16 小时和再灌注 2 小时后,研究了 EVs 提供的心脏保护作用及其机制。钙离子载体诱导 HEK293 细胞释放异质 EVs 群体。在 H9c2 和 AC16 细胞中,应激 EVs 诱导 TLR4 和血红素加氧酶 1 (HO-1) 在 H9c2 细胞中的下游信号转导。应激 EVs 减少了由于模拟缺血/再灌注损伤引起的 H9c2 和 AC16 细胞的坏死,这与 TLR4 诱导无关,但与 HO-1 诱导无关。钙离子载体诱导的 EVs 通过 TLR4 非依赖性方式诱导 HO-1 发挥细胞保护作用。